국가: 영국
언어: 영어
출처: MHRA (Medicines & Healthcare Products Regulatory Agency)
Benzoyl peroxide
Galderma (UK) Ltd
D10AE01
Benzoyl peroxide
50mg/1gram
Cutaneous gel
Cutaneous
No Controlled Drug Status
Valid as a prescribable product
BNF: 13060100; GTIN: 5020465125600 5020465200383
OBJECT 1 ACNECIDE 5% W/W GEL Summary of Product Characteristics Updated 18-Jan-2018 | Galderma (U.K) Ltd 1. Name of the medicinal product Acnecide 5% w/w Gel 2. Qualitative and quantitative composition Hydrous benzoyl peroxide equivalent to Benzoyl Peroxide 5% w/w For the full list of excipients, see section 6.1. 3. Pharmaceutical form Topical Gel White to off-white, smooth gel 4. Clinical particulars 4.1 Therapeutic indications Topical therapy for the treatment of acne vulgaris 4.2 Posology and method of administration For external use only. Adults and children: Before each application, the skin should be cleaned and dried. Apply in a thin layer once or twice daily or as directed to the affected areas. Persons with sensitive skin should be directed to apply the gel once daily before going to bed. The extent of any drying or peeling may be adjusted by modifying the dosage schedule. 4.3 Contraindications Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. 4.4 Special warnings and precautions for use For external use only. Acnecide may cause swelling and blistering of the skin, if any of these symptoms occur, medication has to be discontinued. A mild burning sensation will probably be felt on first application and some reddening and peeling of the skin will occur within a few days. During the first weeks of treatment a sudden increase in peeling will occur in most patients. This is not harmful and will normally subside within a day or two if treatment is temporarily discontinued. If severe irritation occurs, patients should be directed to use the medication less frequently, to temporarily discontinue use or to discontinue use altogether. Patients should be advised that excessive application will not improve efficacy, but may increase the risk of skin irritation. Concomitant topical acne therapy should be used with caution because a possible cumulative irritancy may occur, which sometimes may be severe, especially with the use of peeling, desquamating, or abrasive agents. Benz 전체 문서 읽기